[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO921951L - Benzofuran-derivater - Google Patents

Benzofuran-derivater

Info

Publication number
NO921951L
NO921951L NO92921951A NO921951A NO921951L NO 921951 L NO921951 L NO 921951L NO 92921951 A NO92921951 A NO 92921951A NO 921951 A NO921951 A NO 921951A NO 921951 L NO921951 L NO 921951L
Authority
NO
Norway
Prior art keywords
alkyl
hydrogen
alkenyl
alkoxy
group
Prior art date
Application number
NO92921951A
Other languages
English (en)
Other versions
NO921951D0 (no
Inventor
Barry Clive Ross
David Middlemiss
David Ian Carter Scopes
Torquil Iain Maclean Jack
Kevin Stuart Cardwell
Michael Dennis Dowle
John Gary Montana
Martin Pass
Duncan Bruce Judd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919110633A external-priority patent/GB9110633D0/en
Priority claimed from GB929201358A external-priority patent/GB9201358D0/en
Priority claimed from GB929205174A external-priority patent/GB9205174D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO921951D0 publication Critical patent/NO921951D0/no
Publication of NO921951L publication Critical patent/NO921951L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Forbindelser med den generelle formel (I). eller et fysiologisk god-. tagbart salt, solvat eller metabolsk labil ester der-. av, hvor. Rbetyr hydrogen, halogen, alkyl, alkenyl, fluoralkyl,. alkoksy, -CHO, -COOH eller -COR;. Ar betyr gruppen. R2 betyr alkyl, alkenyl, alkoksy eller -NRl;>R. R3 betyr -COOH, -NHSO CF eller en C-bundet tetrazolyl-gruppe;. R og R , er hver hydrogen, halogen eller alkyl;. Het betyr gruppen. A betyr forskjellige 4-leddede, eventuelt substituerte bindin-ger; spesielt en pyridinring;. betyr et hydrogen, alkyl, alkenyl, alkyltio, alkoksy,. cykloalkyl eller cykloalkylalkyl; og. R5 og1, betyr hver hydrogen eller alkyl, eller -NR15danner en mettet 5- eller 6-leddet heterocyklisk ring som eventuelt kan inneholde et oksygenatom, er nyttige for behand-ling eller profylakse ved hypertensjon og andre sykdommer forbundet med kognitive forstyrrelser.
NO92921951A 1991-05-16 1992-05-15 Benzofuran-derivater NO921951L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919110633A GB9110633D0 (en) 1991-05-16 1991-05-16 Chemical compounds
GB929201358A GB9201358D0 (en) 1992-01-22 1992-01-22 Chemical compounds
GB929205174A GB9205174D0 (en) 1992-03-10 1992-03-10 Chemical compounds

Publications (2)

Publication Number Publication Date
NO921951D0 NO921951D0 (no) 1992-05-15
NO921951L true NO921951L (no) 1992-11-17

Family

ID=27265657

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92921951A NO921951L (no) 1991-05-16 1992-05-15 Benzofuran-derivater

Country Status (15)

Country Link
US (1) US5317023A (no)
EP (1) EP0514197A1 (no)
JP (1) JPH06507608A (no)
KR (1) KR920021542A (no)
AU (2) AU1751192A (no)
CA (1) CA2068756A1 (no)
CZ (1) CZ242993A3 (no)
FI (1) FI935043A (no)
HU (1) HUT67014A (no)
IE (1) IE921569A1 (no)
IL (1) IL101888A0 (no)
MX (1) MX9202300A (no)
NO (1) NO921951L (no)
TW (1) TW221997B (no)
WO (1) WO1992020679A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9110636D0 (en) * 1991-05-16 1991-07-03 Glaxo Group Ltd Chemical compounds
DE4140519A1 (de) * 1991-12-09 1993-06-17 Merck Patent Gmbh Benzofurane
GB9218449D0 (en) 1992-08-29 1992-10-14 Boots Co Plc Therapeutic agents
GB9223860D0 (en) * 1992-11-13 1993-01-06 Glaxo Group Ltd Chemical compounds
GB2279346A (en) * 1993-07-01 1995-01-04 Glaxo Group Ltd Benzofuran intermediates
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
CA2557276A1 (en) * 2004-02-26 2005-09-09 Kyowa Hakko Kogyo Co., Ltd. Preventive and/or therapeutic agent for neutrophilic inflammatory diseases
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CN101772513B (zh) 2007-06-04 2013-11-13 协同医药品公司 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
AU2014274812B2 (en) 2013-06-05 2018-09-27 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase C, method of making and using same

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
DE3928177A1 (de) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA2016710A1 (en) * 1989-05-15 1990-11-15 Prasun K. Chakravarty Substituted benzimidazoles as angiotensin ii antagonists
IE64514B1 (en) * 1989-05-23 1995-08-09 Zeneca Ltd Azaindenes
GB8911854D0 (en) * 1989-05-23 1989-07-12 Ici Plc Heterocyclic compounds
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
EP0415886A3 (en) * 1989-08-30 1991-10-23 Ciba-Geigy Ag Aza compounds
IE70593B1 (en) * 1989-09-29 1996-12-11 Eisai Co Ltd Biphenylmethane derivative the use of it and pharmacological compositions containing same
IL95975A (en) * 1989-10-24 1997-06-10 Takeda Chemical Industries Ltd N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
IL96019A0 (en) * 1989-10-31 1991-07-18 Fujisawa Pharmaceutical Co Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GB8927277D0 (en) * 1989-12-01 1990-01-31 Glaxo Group Ltd Chemical compounds
EP0430300A3 (en) * 1989-12-01 1992-03-25 Takeda Chemical Industries, Ltd. Xanthine derivatives, their production and use
EP0434038A1 (en) * 1989-12-22 1991-06-26 Takeda Chemical Industries, Ltd. Fused imidazole derivatives, their production and use
DE4006693A1 (de) * 1990-03-01 1991-09-05 Schering Ag Neue benzimidazolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
JPH04235974A (ja) * 1990-06-08 1992-08-25 Roussel Uclaf 新規なイミダゾール誘導体、それらの製造法、得られる新規な中間体、それらの薬剤としての使用及びそれらを含有する製薬組成物
DE4140519A1 (de) * 1991-12-09 1993-06-17 Merck Patent Gmbh Benzofurane

Also Published As

Publication number Publication date
IE921569A1 (en) 1992-11-18
MX9202300A (es) 1992-11-01
IL101888A0 (en) 1992-12-30
AU1751192A (en) 1992-12-30
KR920021542A (ko) 1992-12-18
JPH06507608A (ja) 1994-09-01
WO1992020679A1 (en) 1992-11-26
NO921951D0 (no) 1992-05-15
CZ242993A3 (en) 1994-03-16
EP0514197A1 (en) 1992-11-19
FI935043A0 (fi) 1993-11-15
FI935043A (fi) 1993-11-15
AU654349B2 (en) 1994-11-03
AU1632092A (en) 1993-03-11
HU9303225D0 (en) 1994-03-28
CA2068756A1 (en) 1992-11-17
TW221997B (no) 1994-04-01
US5317023A (en) 1994-05-31
HUT67014A (en) 1995-01-30

Similar Documents

Publication Publication Date Title
NO921951L (no) Benzofuran-derivater
NO962539D0 (no) 5-(2-imidazolinylamino)benzimidazol-derivater, deres fremstilling og deres anvendelse som -2-adreniceptor-agonister
DK5389A (da) Substituerede pyrroler, pyrazoler og triazoler, fremgangsmaader til deres fremstilling samt deres anvendelse som angiotensin ii-antagonister
DK0454621T3 (da) Nematodicide midler
BR1100931A (pt) Compostos derivados de aril-heteroaril carbinóis, processos para a preparação dos compostos, composições farmacêuticas, e, uso dos compostos derivados de aril-heteroaril carbinóis
PE20020506A1 (es) Derivados de pirazol fusionados como inhibidores de la proteina cinasa
SE7907121L (sv) Ftalimidinderivat
NO883487D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
NO156203C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 6alfa-methylprednisolon-derivater.
ATE7598T1 (de) Einen halogen enthaltenden substituenten umfassende 2-alkoxycarbonylaminobenzimidazole, ihre herstellung und ihre verwendung als parasitizide.
ATE70274T1 (de) Substituierte 1,8-naphthyridin-derivate und diese enthaltende fungizide.
FI863565A0 (fi) Foerfarande foer framstaellning av nya pyrrobenzimidazoler, pyrrolbenzoxazoler och pyrrolbenztiazoler.
ES523264A0 (es) Procedimiento para la preparacion de 2-(3-piridil)-1,3,4-oxadiazoles
MA21781A1 (fr) Esters ((1,3,5,-triazine-2-yl) aminocarboxyl)-aminosulfonyl) benzoiques herbicides, procedes pour leur preparation et leur utilisation .
ES2069313T3 (es) Utilizacion de derivados de tiazoloisoindolinona como medicamentos antiviricos.
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
ATE189894T1 (de) Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel
DK422688D0 (da) Substituerede pyridylethanolaminer og fysiologisk acceptable salte og n-oxider deraf, deres fremstilling og anvendelse samt mellemprodukter og disses fremstilling
PT85822A (pt) Process for preparing indolo-pyrazino-benzodiazepine derivatives
ES471354A1 (es) Procedimiento para la obtencion de derivados de r,s-2-(2 hi-droxietilamina)-1-fenil-etilamina
ES2021940A6 (es) Procedimiento para la preparacion de nuevos derivados de pirimidina con actividad serotoninergica.
DE3167347D1 (en) New benzothiazine derivatives, processes for preparation thereof and use thereof
DE60201264D1 (de) Benzoaxathiepin-derivate und deren medizinische verwendung
NO166179C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aralkyl -4h-1,2,4-triazolderivater.
ES473737A1 (es) Procedimiento para la preparacion de triazapentadienos.